Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if OM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 10 days ago
Red flags: 0
92 filers reported a long position in OM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $11.8M | 2.7M | 0% |
| BML Capital Management, LLC | $10.9M | 2.5M | +32.5% |
| AQR CAPITAL MANAGEMENT LLC | $4.3M | 999K | +23.6% |
| PERCEPTIVE ADVISORS LLC | $3.6M | 833.3K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.4M | 780.1K | +2.1% |
| BANK OF AMERICA CORP /DE/ | $2.9M | 665.8K | -29.9% |
| PFM Health Sciences, LP | $2.5M | 582.1K | -2.1% |
| Ensign Peak Advisors, Inc | $1.9M | 434.3K | -17.5% |
| BlackRock, Inc. | $1.8M | 418.2K | -66.9% |
| Assenagon Asset Management S.A. | $1.5M | 339.4K | -32.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.